CLOV Hedge Fund Ownership (Q2 2026)

Clover Health Investments Co (CLOV)

221 + Investors. Track Smart Money conviction in CLOV. See who's accumulating, reducing, or initiating positions.

Smart Money Signals — CLOV

Based on 226 hedge funds · latest filing: 2026 Q2 · updated quarterly

📈

Buying streak — 2 quarters in a row

last 6Q

For 2 consecutive quarters, more hedge funds added CLOV than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

🏔️

At the ownership peak (100% of max)

100% of all-time peak

226 hedge funds hold CLOV right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.

📶

Steady growth — +15% more funds vs a year ago

fund count last 6Q

+30 new funds entered over the past year (+15% YoY). Gradual, steady growth in institutional ownership is generally a healthy signal — not a speculative rush, but consistent conviction.

🟢

More buyers than sellers — 61% buying

129 buying81 selling

Last quarter: 129 funds were net buyers (50 opened a brand new position + 79 added to an existing one). Only 81 were sellers (52 trimmed + 29 sold completely). A clear majority buying is a strong confirmation signal.

➡️

Steady new buyers — ~50 new funds per quarter

new funds entering per quarter

Funds opening this position for the first time: 32 → 31 → 47 → 50. A stable flow of new institutional buyers suggests ongoing interest without signs of either acceleration or slowdown.

🔒

49% of holders stayed for 2+ years

■ 49% conviction (2yr+) ■ 24% medium ■ 27% new

111 out of 226 hedge funds have held CLOV for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

💰

Value +451% but shares only +20% — price-driven

Value

+451%

+20%

Last quarter: the total dollar value of institutional holdings rose +451%, but actual share count only changed +20%. The gap is explained by the stock's price rising — not new buying. Strong value growth with weak share growth means the rally is price momentum, not fresh institutional demand.

🚀

Acceleration phase — new buyers rushing in

54 → 32 → 31 → 47 → 50 new funds/Q

New funds entering each quarter: 32 → 31 → 47 → 50. The pace of institutional discovery is accelerating sharply. This is the 'hot idea' phase — the thesis is being passed from fund to fund. You are not late — the accumulation wave is still building.

🏛️

Veteran-anchored — 59% veterans vs 30% newcomers

■ 59% veterans ■ 12% 1-2yr ■ 30% new

Entry-cohort mix of 237 holders: 139 (59%) are 2+ year veterans, 28 entered 1–2 years ago, and 70 (30%) joined within the past year. A veteran-weighted cap table skews toward institutional memory over fresh momentum.

🏆

Elite ownership — 77% AUM from top-100 funds

77% from top-100 AUM funds

45 of 224 holders are among the 100 largest funds by AUM, controlling 77% of total institutional value in CLOV. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.

3.9

out of 10

Low Exit Risk

Exit risk score 3.9/10 — low institutional crowding. Ownership is below peak levels, holder base is relatively sticky, and buying momentum is positive.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Metric	All 13F Filers (2026 Q2)	Prior (2026 Q1)	Change
Funds Holding	221	205	7.8%
13F Shares	159M	134M	18.64%
Total Value	$823M	$233M	253.11%
New Positions	49	47	+2
Increased Positions	77	57	+20
Closed Positions	31	32	-1
Reduced Positions	48	53	-5
Total Calls	8	6	33.33%
Total Puts	5	5	-
PUT/CALL Ratio	0.62	0.83	Bullish

Metric

All 13F Filers (2026 Q2)

Prior (2026 Q1)

Change

Funds Holding

221

205

7.8%

13F Shares

159M

134M

18.64%

Total Value

$823M

$233M

253.11%

New Positions

Increased Positions

+20

Closed Positions

-1

Reduced Positions

-5

Total Calls

33.33%

Total Puts

PUT/CALL Ratio

0.62

0.83

Bullish

Institutional Holders (2026 Q2)

221 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in CLOV. Verified SEC 13F-HR filings.

QUARTER:

FILTER:All New Added To Reduced No Change | Overweight >5%

Top 25 CLOV holders by conviction (% of portfolio weight) — 2026 Q2 · Source: SEC Form 13F
#	Investor	% of Portfolio	Shares	Mkt Value
1	Gmt Capital Corp	0.36%	1,305,200	$6.8M
2	Palacios Wealth Management, LLC	0.16%	51,624	$271K
3	Caxton Associates LLP	0.12%	1,216,631	$6.4M
4	nVerses Capital, LLC	0.09%	11,627	$61K
5	Axq Capital, LP	0.08%	146,569	$768K
6	Viewpoint Capital Management LLC	0.08%	30,000	$157K
7	Turtle Creek Wealth Advisors, LLC	0.06%	220,000	$1.2M
8	Atom Investors LP	0.06%	122,871	$644K
9	Silverleafe Capital Partners, LLC	0.06%	40,000	$210K
10	State of Wyoming	0.04%	78,872	$413K
11	Headlands Technologies LLC	0.04%	72,378	$379K
12	Aquatic Capital Management LLC	0.04%	214,443	$1.1M
13	WINTON GROUP Ltd	0.03%	174,157	$913K
14	Fortress Private Ledger, LLC	0.03%	20,200	$106K
15	Alteri Wealth LLC	0.03%	19,160	$100K
16	Caitong International Asset Management Co., Ltd	0.03%	38,464	$202K
17	Ketron Financial	0.03%	16,708	$88K
18	SeaCrest Wealth Management, LLC	0.02%	41,100	$215K
19	Algert Global LLC	0.02%	375,080	$2.0M
20	Quantbot Technologies LP	0.02%	105,250	$552K
21	Renaissance Technologies LLC	0.02%	2,807,441	$14.7M
22	Aigen Investment Management, LP	0.02%	13,481	$71K
23	Anchyra Partners LLC	0.02%	15,226	$80K
24	FreeGulliver LLC	0.02%	10,000	$52K
25	Kestra Private Wealth Services, LLC	0.02%	276,007	$1.4M

Investor	Ownership History	% of Portfolio	Prev %	Rank	Conviction	Avg Buy Price	13F Score™ 3Y / 7Y	Sell Timing	Shares	Mkt Value	Change	Change %	Source	Quarter	Filed

Frequently Asked Questions — Clover Health Investments Co (CLOV)

What does the Smart Money Trend signal show for CLOV?

Buying streak — 2 quarters in a row: For 2 consecutive quarters, more hedge funds added CLOV than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for CLOV?

More buyers than sellers — 61% buying: Last quarter: 129 funds were net buyers (50 opened a brand new position + 79 added to an existing one). Only 81 were sellers (52 trimmed + 29 sold completely). A clear majority buying is a strong confirmation signal.

What is the fund quality score for CLOV holders?

Elite ownership — 77% AUM from top-100 funds: 45 of 224 holders are among the 100 largest funds by AUM, controlling 77% of total institutional value in CLOV. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.

How long have hedge funds held CLOV?

49% of holders stayed for 2+ years: 111 out of 226 hedge funds have held CLOV for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Market Cap	--
Enterprise Value	--
Trailing P/E	--
Forward P/E	--
PEG Ratio (5yr expected)	--
Price/Sales (ttm)	--
Price/Book (mrq)	--
Enterprise Value/Revenue	--
Enterprise Value/EBITDA	--
Beta (5Y Monthly)	--
Short Ratio (Days to Cover)	--
Short % of Float	--

Profit Margin	--
Return on Assets (ttm)	--
Return on Equity (ttm)	--

Revenue (ttm)	--
Net Income Avi to Common (ttm)	--
Diluted EPS (ttm)	--
Total Cash (mrq)	--
Total Debt/Equity (mrq)	--
Levered Free Cash Flow (ttm)	--

Clover Health Investments Co (CLOV)

Smart Money Signals — CLOV

Buying streak — 2 quarters in a row

At the ownership peak (100% of max)

Steady growth — +15% more funds vs a year ago

More buyers than sellers — 61% buying

Steady new buyers — ~50 new funds per quarter

49% of holders stayed for 2+ years

Value +451% but shares only +20% — price-driven

Acceleration phase — new buyers rushing in

Veteran-anchored — 59% veterans vs 30% newcomers

Elite ownership — 77% AUM from top-100 funds

Institutional Sentiment Summary — CLOV

Hedge Fund Ownership: CLOV

Market Analysis: CLOV

Analyst Price Targets

Analyst Recommendations

Stock Performance

Company Profile: CLOV

Hedge Fund Positioning: CLOV

Statistics: CLOV

Valuation Measures Data as of: --

Financial Highlights

Institutional Holders (2026 Q2)

Frequently Asked Questions — Clover Health Investments Co (CLOV)

Welcome to 13Foresight!